German Velasquez gvelasquez.gva at gmail.com
Tue Dec 6 09:35:58 PST 2016

​ (to be delivered at the UNAIDS PCB on 7 December, 2016​)
On September 2016, the UN Secretary-General High-Level Panel on Access to
Medicines released its report that was adopted by consensus and recently
endorsed by the Secretary General. UNDP and UNAIDS secretariat served as
the Panel’s secretariat. The report advances important recommendations. The
South Centre, in a statement released in September this year, endorsed the
report and called on governments, the United Nations entities and others
including the World Trade Organization, to take action on the report’s
recommendations. We also commend the engagement of UNAIDS in this landmark

The HLP report recommends that “*Governments and the private Sector must
refrain from explicit or implicit threats, tactics or strategies that
undermine the right of WTO members to use flexibilities. Instances of undue
political pressure should be reported to the WTO Secretariat during the
trade policy review of members. WTO Members must register complaints
against undue political and economic pressure which includes taking
punitive measures against offending WTO Members.*” The South Centre
supports this recommendation, recognizing that many countries, as
exemplified by the recent case of Colombia, face unjustifiable barriers in
making effective use of flexibilities to promote access to medical
technologies that are allowed under international intellectual property

The South Centre also supports the recommendations of the HLP report to
explore and invest in new mechanisms that delink the costs of research and
development (R&D) from the end prices of health technologies, to promote
innovation and affordable access— including negotiations for a binding R&D

The South Centre also supports the HLP report recommendations on disclosure
of results of publicly-funded research, and strengthening governance,
accountability and transparency to promote innovation and ensure access to
health technologies.

*The South Centre therefore recommends that the UNAIDS Programme
Coordinating Board: *


   *Welcome* the report of the UN Secretary-General’s High-Level Panel on
   Access to Medicines; and take immediate action to support Members States
   to implement the recommendations relevant to them;

   *Instruct* the UNAIDS
   ​to ​
   explore new mechanisms that delink costs of R&D for end prices of health
   technologies for HIV/AIDS treatment and ensure their affordable access; and


   *Reaffirm* the critical importance of addressing intellectual
   property-related factors that impact on the availability and affordability
   of treatments for HIV/AIDS.

More information about the Ip-health mailing list